Newsletter Archive

Autism Research Institute
Autism Research Review International
1987 to 2006, Volumes 1 to 20

a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z  

P

P-Touch Electronic Labeling device, 1992, Vol. 06(4) pp. 3
"pacemaker " (vagus nerve stimulator), 1997, Vol. 11(4) pp. 2; 2001, Vol. 15(2) pp. 7; 2002, Vol. 16(3) pp. 5.
Page, Ted, 2001, Vol. 15(1) pp. 7
pagers, 2004, Vol. 18(2) pp. 5
Pahl, Jan, 1987, Vol. 01(2) pp. 4
pain

pain threshold, 1993, Vol. 07(4) pp. 4; 1994, Vol. 08(3) pp. 2.
Palace, J., 2001, Vol. 15(1) pp. 7
palatinase, 2006, Vol. 20(1) pp. 4
Palfreman, John, 1993, Vol. 07(4) pp. 7
Pallanti, Stefano, 2005, Vol. 19(4) pp. 5
palm creases, 1990, Vol. 04(2) pp. 4
Palmer, Monica Rourke, 1992, Vol. 06(1) pp. 7
Palmer, Pat, 1998, Vol. 12(3) pp. 2; 1999, Vol. 13(2) pp. 6.
pancreatic dysfunction, 2000, Vol. 14(3) pp. 6; 2005, Vol. 19(3) pp. 1; 2005, Vol. 19(4) pp. 4.
PANDAS. See pediatric autoimmune neuropsychiatric disorders (PANDAS)
Paneth cell hyperplasia, 1999, Vol. 13(4) pp. 7
pangamic acid (vitamin B15), 1990, Vol. 04(2) pp. 3
Pangborn, Jon

panic attacks, 1999, Vol. 13(1) pp. 2; 2001, Vol. 15(1) pp. 6.
Panksepp, Jaak

Papanikolaou, P.N., 2004, Vol. 18(4) pp. 4
paranoid symptoms, 1998, Vol. 12(2) pp. 3
paraoxon, 2006, Vol. 20(3) pp. 7
paraquat, 2006, Vol. 20(3) pp. 7
parathion, 2006, Vol. 20(3) pp. 7
parathyroid hormone, 1998, Vol. 12(3) pp. 6; 2005, Vol. 19(2) pp. 4.
Pardo, Sandra Bosso, 1992, Vol. 06(4) pp. 6
Parent Designed Report Form, 2005, Vol. 19(4) pp. 3
Parent Idea Book (compiled by International Rett Symdrome Association), 1989, Vol. 03(4) pp. 7
parents, 1994, Vol. 08(3) pp. 4; 2005, Vol. 19(1) pp. 2. See also family of autistics
"pareve" label, 2000, Vol. 14(3) pp. 6
parietal lobe abnormalities, 1990, Vol. 04(2) pp. 4; 1993, Vol. 07(3) pp. 4; 1994, Vol. 08(2) pp. 1; 1994, Vol. 08(3) pp. 5; 1997, Vol. 11(1) pp. 1; 2001, Vol. 15(2) pp. 4.
PARISS genetic study, 2000, Vol. 14(1) pp. 2
Park, Clara, 1990, Vol. 04(1) pp. 7
parkinsonism, 1997, Vol. 11(1) pp. 4; 2000, Vol. 14(4) pp. 4; 2003, Vol. 17(4) pp. 4.
Parkinson's, 1989, Vol. 03(3) pp. 7; 2001, Vol. 15(3) pp. 7; 2001, Vol. 15(4) pp. 2; 2002, Vol. 16(3) pp. 4.
paroxetine (Paxil), 2002, Vol. 16(4) pp. 6; 2003, Vol. 17(3) pp. 2; 2004, Vol. 18(2) pp. 4; 2004, Vol. 18(3) pp. 2; 2006, Vol. 20(2) pp. 2.
Parr, Janette M., 1989, Vol. 03(3) pp. 5
Parran, Damani, 2005, Vol. 19(1) pp. 4
pars opercularis, 2005, Vol. 19(4) pp. 2
Parsons, S., 2002, Vol. 16(3) pp. 5
partial reinforcement, 1994, Vol. 08(3) pp. 5
Partington, M. W., 1998, Vol. 12(3) pp. 5
Pasca, Sergiu, 2005, Vol. 19(4) pp. 1
passive behavior, 2002, Vol. 16(3) pp. 1; 2003, Vol. 17(4) pp. 6.
Pasteur, Sanofi, 2006, Vol. 20(2) pp. 4
patent theft, 2002, Vol. 16(1) pp. 3
pathological demand avoidance syndrome (PDA), 2003, Vol. 17(4) pp. 6
Patrick, Louise, 2005, Vol. 19(4) pp. 2
pattern recognition in savants, 1989, Vol. 03(1) pp. 7
Paul, Rhea, 1988, Vol. 02(4) pp. 7
Paul-Brown, Diane, 1994, Vol. 08(3) pp. 7
Pauling, Linus, 1995, Vol. 09(1) pp. 2; 1997, Vol. 11(4) pp. 3; 2000, Vol. 14(3) pp. 3.
Pavley, Fran (Assemblywoman), 2004, Vol. 18(3) pp. 1
Paxil (paroxetine), 2002, Vol. 16(4) pp. 6; 2003, Vol. 17(3) pp. 2; 2004, Vol. 18(2) pp. 4; 2004, Vol. 18(3) pp. 2; 2006, Vol. 20(2) pp. 7.
pay-per-view study, 2005, Vol. 19(1) pp. 7
PC language, 1992, Vol. 06(3) pp. 6; 1993, Vol. 07(4) pp. 3; 1994, Vol. 08(1) pp. 6.
PCBs, 2006, Vol. 20(1) pp. 3
PCR test, 1995, Vol. 09(3) pp. 1
PDA (pathological demand avoidance syndrome), 2003, Vol. 17(4) pp. 6
PDD. See pervasive developmental disorder
Peale, Norman Vincent, 1994, Vol. 08(3) pp. 6
Peck, Charles, 1988, Vol. 02(1) pp. 6; 1988, Vol. 02(2) pp. 6; 1994, Vol. 08(4) pp. 6.
PECS (Picture-Exchange Communication System), 1995, Vol. 09(3) pp. 5; 2002, Vol. 16(3) pp. 5; 2002, Vol. 16(4) pp. 2.
Pediacel, 2006, Vol. 20(2) pp. 4
Pediatric Advisory Committee, 2006, Vol. 20(2) pp. 2
pediatric anesthetic problem register, 1999, Vol. 13(3) pp. 5
Pediatric Autism Research Act, 1998, Vol. 12(3) pp. 6
pediatric autoimmune neuropsychiatric disorders (PANDAS)

pediazole, 1992, Vol. 06(4) pp. 4
peer relationships, 2002, Vol. 16(3) pp. 1
peer training, 1987, Vol. 01(2) pp. 5
peer tutors, 1988, Vol. 02(1) pp. 7; 1994, Vol. 08(4) pp. 6.
Peet, Malcolm, 1999, Vol. 13(1) pp. 7
Pekow, Charles, 1990, Vol. 04(4) pp. 6
pemoline (Cylert), 2000, Vol. 14(1) pp. 2; 2005, Vol. 19(3) pp. 4.
Penn, Joseph, 2005, Vol. 19(3) pp. 3
Pennsylvania, 2004, Vol. 18(4) pp. 3
Pentacel, 2006, Vol. 20(2) pp. 4
pentoxifylline (PTX), 1997, Vol. 11(1) pp. 1; 1997, Vol. 11(2) pp. 7.
Penzel, Fred, 1997, Vol. 11(2) pp. 1–2
people-first language, 1992, Vol. 06(3) pp. 6; 1993, Vol. 07(4) pp. 3; 1994, Vol. 08(1) pp. 6.
Pepcid (famotidine)

Pepperberg, Irene M., 2001, Vol. 15(1) pp. 6
peptidase, 2000, Vol. 14(1) pp. 6
peptide analysis, 2000, Vol. 14(1) pp. 7
peptide analysis website, 2002, Vol. 16(1) pp. 7
peptides

perceptual feedback, 1988, Vol. 02(2) pp. 2
perceptual problems, 1997, Vol. 11(1) pp. 5
Perceptual Science Laboratory, 2001, Vol. 15(4) pp. 5
perchlorate

perfect pitch, 2003, Vol. 17(4) pp. 4
periamygdaloid region, 2005, Vol. 19(4) pp. 2
Pericak-Vance, Margaret A., 2001, Vol. 15(2) pp. 5; 2003, Vol. 17(1) pp. 6; 2005, Vol. 19(3) pp. 6.
peripheral neuropathy, 1996, Vol. 10(3) pp. 3; 1997, Vol. 11(4) pp. 3; 2001, Vol. 15(3) pp. 7.
Perkins, M., 1992, Vol. 06(1) pp. 4
permissiveness, 1987, Vol. 01(1) pp. 3
Peroutka, Stephen, 1989, Vol. 03(1) pp. 4
peroxidation, 2005, Vol. 19(4) pp. 2; 2006, Vol. 20(4) pp. 1.
Perry, D. W., 1997, Vol. 11(2) pp. 4
Perry, Elaine K., 2001, Vol. 15(3) pp. 7
Perry, George, 2005, Vol. 19(2) pp. 2
Perry, Richard, 1994, Vol. 08(3) pp. 3; 1995, Vol. 09(1) pp. 5.
perseveration

Persico, Antonio M., 2000, Vol. 14(1) pp. 1; 2001, Vol. 15(2) pp. 1.
perspective, 2003, Vol. 17(1) pp. 5
Perspectives on the Use of Nonaversive and Aversive Interventions for Persons with Developmental Disabilities (ed. Repp and Singh), 1991, Vol. 05(2) pp. 7
pertussis vaccine, 1996, Vol. 10(1) pp. 3
"pervasive," 1991, Vol. 05(2) pp. 2; 1991, Vol. 05(4) pp. 7.
pervasive developmental disorder (PDD)

Pessah, Isaac N., 2006, Vol. 20(1) pp. 1
pesticides, 2006, Vol. 20(3) pp. 7
PET (positron emission tomography) scans, 1988, Vol. 02(1) pp. 4
pet therapy, 1989, Vol. 03(4) pp. 2
Peter, Laurence J., 1990, Vol. 04(1) pp. 6
Peter Principle (Peter), 1990, Vol. 04(1) pp. 6
Peter (savant), 1989, Vol. 03(1) pp. 3
Peters, Jimmy, 1994, Vol. 08(4) pp. 2
Peters, K. K. (Judge), 1992, Vol. 06(3) pp. 1
Peters, Sarika, 2004, Vol. 18(4) pp. 6
Petersilia, Joan, 2000, Vol. 14(2) pp. 6–7
Petit, M., 1990, Vol. 04(1) pp. 7
Petty, L., 1987, Vol. 01(3) pp. 4
Pfeiffer Treatment Center, 1997, Vol. 11(3) pp. 1; 2004, Vol. 18(4) pp. 7.
Pfizer (drug company), 2004, Vol. 18(4) pp. 3
Pharmaceutical Information Network, 1996, Vol. 10(3) pp. 4
pharmaceutical treatments. See drugs
pharmacy errors, 1996, Vol. 10(3) pp. 4
phenobarbital, 1990, Vol. 04(1) pp. 6; 1991, Vol. 05(1) pp. 3; 1993, Vol. 07(4) pp. 5; 2004, Vol. 18(3) pp. 4.
phenol-alanine, 2002, Vol. 16(1) pp. 7
phenol-sulphotransferase-P, 1994, Vol. 08(1) pp. 4
phenols

phenylalanine, 2003, Vol. 17(3) pp. 6
phenylketonuia (PKU)

phenylpyridinium, 2006, Vol. 20(3) pp. 7
phenytoin (Dilantin)

Philippart, Michel, 1987, Vol. 01(2) pp. 6; 1989, Vol. 03(1) pp. 4; 1990, Vol. 04(3) pp. 5.
Philippe Augsute Laboratory, 2006, Vol. 20(3) pp. 7
Philippi, Anne, 2005, Vol. 19(3) pp. 6
Philippines, 2003, Vol. 17(1) pp. 7
Phillip Institute, 1992, Vol. 06(1) pp. 1
Phillips, Lou Diamond, 2004, Vol. 18(3) pp. 1
Phillips, Wendy, 1993, Vol. 07(2) pp. 4
phobias, 1998, Vol. 12(4) pp. 4
phosphorylation, 2006, Vol. 20(2) pp. 6
physical peculiarities, 2000, Vol. 14(1) pp. 4
Physicians Committee for Responsible Medicine (PCRM)

Piazza, Cathleen, 1997, Vol. 11(4) pp. 6
pica

Piccolo, Richard, 1998, Vol. 12(1) pp. 3
Pichichero, Michael, 2002, Vol. 16(1) pp. 4
picky eating, 2003, Vol. 17(4) pp. 5
picture books, 1994, Vol. 08(3) pp. 7
Picture-Exchange Communication System (PECS), 1995, Vol. 09(3) pp. 5; 2002, Vol. 16(3) pp. 5; 2002, Vol. 16(4) pp. 2.
pictures, 1998, Vol. 12(4) pp. 6–7
Pierce, Karen L., 1994, Vol. 08(3) pp. 7; 2000, Vol. 14(3) pp. 4; 2004, Vol. 18(3) pp. 7.
Pietz, J., 1994, Vol. 08(1) pp. 1; 1995, Vol. 09(4) pp. 3; 1996, Vol. 10(3) pp. 3.
Piggott, Leonard, 1987, Vol. 01(3) pp. 2
pill taking, 2001, Vol. 15(4) pp. 7
pimozine (ORAP), 2000, Vol. 14(1) pp. 4
Pina, Jorge, 1989, Vol. 03(4) pp. 2
Pinchichero, Michael E., 2002, Vol. 16(4) pp. 1
pineal gland, 1994, Vol. 08(3) pp. 2
Pineda, Jaime A., 2005, Vol. 19(1) pp. 5; 2006, Vol. 20(2) pp. 4.
pink disease, 2000, Vol. 14(4) pp. 3
pink urine, 2005, Vol. 19(4) pp. 3
Pioggia, Giovanni, 2006, Vol. 20(1) pp. 7
pioglitazone. See Actos
piracetam, 1995, Vol. 09(1) pp. 6; 1996, Vol. 10(2) pp. 7.
Pisani, David (March of Dimes), 2000, Vol. 14(2) pp. 6
pitocin, 1996, Vol. 10(3) pp. 2; 1997, Vol. 11(4) pp. 7; 2001, Vol. 15(1) pp. 4.
Pitsas, Marian, 1993, Vol. 07(4) pp. 6; 1994, Vol. 08(1) pp. 5.
Pittler, Max H., 2000, Vol. 14(2) pp. 4
pituitary, 1987, Vol. 01(4) pp. 7; 1991, Vol. 05(2) pp. 5; 2006, Vol. 20(3) pp. 6.
Piven, Joseph, 1991, Vol. 05(2) pp. 4; 1995, Vol. 09(3) pp. 2; 1998, Vol. 12(3) pp. 2; 1999, Vol. 13(2) pp. 6.
pivotal response training, 1992, Vol. 06(2) pp. 5; 1994, Vol. 08(1) pp. 5; 1995, Vol. 09(3) pp. 4; 2005, Vol. 19(2) pp. 5.
PKU. See phenylketonuria
plasmapheresis, 1996, Vol. 10(3) pp. 1; 1999, Vol. 13(1) pp. 5; 1999, Vol. 13(3) pp. 7.
platelets, 2006, Vol. 20(4) pp. 5
Platt, Mike L., 2005, Vol. 19(1) pp. 7
play

PLAY Project, 2003, Vol. 17(2) pp. 5
Please Don't Say Hello (Gold), 1989, Vol. 03(3) pp. 6
Plienis, Anthony, 1988, Vol. 02(4) pp. 2
Plioplys, Andreas, 1989, Vol. 03(2) pp. 7; 1998, Vol. 12(2) pp. 1; 2004, Vol. 18(3) pp. 6.
Plioplys, Audrius V., 1994, Vol. 08(2) pp. 4
Plochl, E., 1996, Vol. 10(3) pp. 4
PMA (Prorated Mental Age), 1987, Vol. 01(3) pp. 6
PMS. See premenstrual syndrome
pneumoccoccus, 2001, Vol. 15(2) pp. 1
pneumonia, 1988, Vol. 02(3) pp. 4
poliomyelitis, 1996, Vol. 10(1) pp. 3
"Polluting our Future" (report by National Environmental Trust, Physicians for Social Responsibility, and the Learning Disabilities Association of America), 2000, Vol. 14(3) pp. 1
pollution. See toxics
polycystic ovary syndrome, 2005, Vol. 19(4) pp. 4
polycythemia, 2004, Vol. 18(1) pp. 6
polydipsia, 1997, Vol. 11(1) pp. 2; 1999, Vol. 13(2) pp. 4.
polymicrogyria, 1990, Vol. 04(3) pp. 4
polymorphisms, 2006, Vol. 20(4) pp. 4
Pomeranz, Kenneth, 1998, Vol. 12(3) pp. 7
PON1 arylesterase, 2005, Vol. 19(4) pp. 1; 2006, Vol. 20(3) pp. 7.
Pondimin. See fenfluramine (Pondimin)
pons, 1988, Vol. 02(4) pp. 1
Pope, Sharon T., 1997, Vol. 11(2) pp. 5
Popper, Charles W., 2002, Vol. 16(1) pp. 2
population studies, 1989, Vol. 03(2) pp. 1
Popynick, Michele, 1994, Vol. 08(1) pp. 5
porphyrins, 2006, Vol. 20(2) pp. 1; 2006, Vol. 20(3) pp. 7.
Porter, Basil, 1992, Vol. 06(3) pp. 5
Porterville Developmental Center, 1997, Vol. 11(1) pp. 3
Portwood, Madeleine, 2006, Vol. 20(2) pp. 4
Posey, David J., 2000, Vol. 14(1) pp. 5; 2004, Vol. 18(4) pp. 5.
positive practice overcorrection, 2001, Vol. 15(1) pp. 5
positive practice skills training, 1987, Vol. 01(1) pp. 5
positive reinforcement, 1987, Vol. 01(1) pp. 3; 1988, Vol. 02(3) pp. 1; 1990, Vol. 04(2) pp. 6.
Posner test, 1993, Vol. 07(3) pp. 4
posterior cingulate, 2006, Vol. 20(2) pp. 7
posterior temporal fusiform gyrus, 2002, Vol. 16(4) pp. 4
posture, 2000, Vol. 14(4) pp. 4; 2001, Vol. 15(2) pp. 5; 2004, Vol. 18(4) pp. 5; 2006, Vol. 20(2) pp. 3.
potassium, 2006, Vol. 20(4) pp. 6
potentializer, 1987, Vol. 01(3) pp. 3
Potenza, M. N., 1999, Vol. 13(3) pp. 4
potty training. See toilet training
Povich, Maury, 1993, Vol. 07(2) pp. 6
Powell, Ellen (March of Dimes), 2000, Vol. 14(2) pp. 6
Power of Positive Thinking (Peale), 1994, Vol. 08(3) pp. 6
power plants and autism, 2005, Vol. 19(1) pp. 1
Powers, Michael D., 1990, Vol. 04(1) pp. 7; 1991, Vol. 05(3) pp. 5.
P5P (pyridoxal-5-phosphate), 2001, Vol. 15(4) pp. 3; 2006, Vol. 20(1) pp. 1; 2006, Vol. 20(2) pp. 6.
PPAR. See Actos
PPI (prepulse inhibition), 2003, Vol. 17(2) pp. 2
Prader-Willi syndrome, 1990, Vol. 04(3) pp. 5; 1997, Vol. 11(4) pp. 4; 2001, Vol. 15(3) pp. 6; 2003, Vol. 17(1) pp. 6.

Pratico, Domenico, 2006, Vol. 20(4) pp. 5
Pratt, Cathy, 2006, Vol. 20(4) pp. 1
PRECOPRO. See precoproporphyrin
precoproporphyrin (PRECOPRO), 2006, Vol. 20(2) pp. 1
precunaeus, 2006, Vol. 20(2) pp. 7
prefrontal cortex, 2002, Vol. 16(1) pp. 1; 2006, Vol. 20(2) pp. 7.
premenstrual syndrome (PMS)

premutations, 1995, Vol. 09(3) pp. 1
prenatal factors. See also birth conditions

prepulse inhibition (PPI), 2003, Vol. 17(2) pp. 2
Prescott, James, 1987, Vol. 01(3) pp. 3
prevalence

Prevent Autism Now, 1994, Vol. 08(3) pp. 6
Prevnar, 2001, Vol. 15(2) pp. 1
priaprism, 2002, Vol. 16(4) pp. 6–7
Price, Michael Lee, 1996, Vol. 10(4) pp. 7
Princeton Child Development Institute, 1992, Vol. 06(2) pp. 5; 1994, Vol. 08(3) pp. 3.
Princeton/Eden Research Award, 1995, Vol. 09(2) pp. 3
Principles of Teaching (Peter), 1990, Vol. 04(1) pp. 6
Prior, Margot

prism lenses

"Prisoners of Silence" (PBS Frontline TV show), 1993, Vol. 07(4) pp. 7
Prizant, Barry, 1990, Vol. 04(3) pp. 6
probiotics, 1988, Vol. 02(2) pp. 3; 2000, Vol. 14(3) pp. 2; 2001, Vol. 15(3) pp. 4.
professional associations

prognosis

program referral list, 1997, Vol. 11(2) pp. 4
Project Peer, 1988, Vol. 02(1) pp. 6
prolactin, 1987, Vol. 01(4) pp. 7; 1999, Vol. 13(4) pp. 4; 2001, Vol. 15(2) pp. 4.
prompts, 1988, Vol. 02(1) pp. 7
Proos, Ylle, 1991, Vol. 05(3) pp. 2
property damage, 1997, Vol. 11(2) pp. 6; 2002, Vol. 16(2) pp. 7; 2003, Vol. 17(1) pp. 3.
propofol, 1999, Vol. 13(3) pp. 5
propranolol, 1990, Vol. 04(3) pp. 7
proprioception, 1987, Vol. 01(3) pp. 3; 1988, Vol. 02(4) pp. 3; 1998, Vol. 12(3) pp. 3. See also balance
Prorated Mental Age, 1987, Vol. 01(3) pp. 6
prosopagnosia, 2004, Vol. 18(3) pp. 7. See also face blindness
prostacyclin, 2006, Vol. 20(4) pp. 5
proteins

protodeclarative pointing, 1996, Vol. 10(2) pp. 6
Prozac. See fluoxetine (Prozac)
pseudo-language, 1989, Vol. 03(1) pp. 2
Psillas, George, 2003, Vol. 17(3) pp. 4
psychogenic model, 1989, Vol. 03(3) pp. 3; 2001, Vol. 15(3) pp. 3; 2006, Vol. 20(3) pp. 1.
Psychological Medicine, 1988, Vol. 02(4) pp. 1
psychomotor seizures, 1990, Vol. 04(1) pp. 4
psychosis, 1988, Vol. 02(4) pp. 7; 2003, Vol. 17(1) pp. 5.
PTEN, 2005, Vol. 19(3) pp. 6
puberty, 2005, Vol. 19(1) pp. 3
Public Citizen, 2005, Vol. 19(3) pp. 4
Public Health Service, U.S., 1992, Vol. 06(3) pp. 5; 2004, Vol. 18(2) pp. 3; 2004, Vol. 18(4) pp. 2.
PubMed, 2001, Vol. 15(1) pp. 7
PUFAs (omega-3 polyunsaturated fatty acids)

Pumpian, Ian, 1990, Vol. 04(3) pp. 2
punishment. See aversives
Purdon, Scot E., 1994, Vol. 08(4) pp. 1; 1996, Vol. 10(2) pp. 2.
purines

Purkinje cells. See also amygdala deficiencies, See also cerebellum deficiencies

putamen, 1997, Vol. 11(4) pp. 4
pycnogenol, 2006, Vol. 20(2) pp. 5; 2006, Vol. 20(4) pp. 7.
pyridium, 2006, Vol. 20(3) pp. 7
pyridoxal 5-phosphate (P5P), 2001, Vol. 15(4) pp. 3; 2006, Vol. 20(1) pp. 1.
pyridoxal phosphate (PLP), 2004, Vol. 18(4) pp. 4; 2005, Vol. 19(1) pp. 2.
pyridoxine, 2002, Vol. 16(2) pp. 2; 2006, Vol. 20(1) pp. 6; 2006, Vol. 20(2) pp. 6. See also vitamin B6
pyridoxine-dependent epilepsy, 2002, Vol. 16(2) pp. 2
pyroluria, 1997, Vol. 11(3) pp. 1